RHUMBLINE ADVISERS

Position in STTK — Shattuck Labs, Inc.

CIK 1115418 BOSTON, MA

Position in STTK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$496,126

+$447,626 QoQ

Shares Held

71,488

+40.0% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 100 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 21% Shared 0% None 79%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. STTK ranks #183 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$496,126	71,488	+40.0%	Shares	Sole	2026-08-12
2025-03-31	$48,500	51,053	+3.7%	Shares	Sole	2025-05-29
2024-12-31	$59,586	49,245	-1.5%	Shares	Sole	2025-05-29
2024-09-30	$174,541	50,012	+5.9%	Shares	Sole	2024-11-12
2024-06-30	$182,365	47,245	+79.8%	Shares	Sole	2024-08-01
2022-03-31	$111,910	26,270	+9.6%	Shares	Sole	2022-05-12
2021-12-31	$203,899	23,960	-1.9%	Shares	Sole	2022-02-10
2021-09-30	$497,944	24,433	+5.3%	Shares	Sole	2021-11-12
2021-06-30	$672,915	23,212	+75.3%	Shares	Sole	2021-08-05
2021-03-31	$387,283	13,245	+6.9%	Shares	Sole	2021-05-06
2020-12-31	$649,255	12,388	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.